webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

bis-PEG2-endo-BCN

  CAS No.: 1476737-97-9   Cat No.: BADC-00955   Purity: >98.0% 4.5  

bis-PEG2-endo-BCN is a bifunctional ADC linker with two endo-BCN groups connected via PEG2 spacer, facilitating dual strain-promoted click conjugations in antibody-drug conjugate synthesis.

bis-PEG2-endo-BCN

Structure of 1476737-97-9

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C28H40N2O6
Molecular Weight
500.63
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
bis(bicyclo[6.1.0]non-4-yn-9-ylmethyl) ((ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))dicarbamate
IUPAC Name
Canonical SMILES
C1CC2C(C2COC(=O)NCCOCCOCCNC(=O)OCC3C4C3CCC#CCC4)CCC#C1
InChI
InChI=1S/C28H40N2O6/c31-27(35-19-25-21-9-5-1-2-6-10-22(21)25)29-13-15-33-17-18-34-16-14-30-28(32)36-20-26-23-11-7-3-4-8-12-24(23)26/h21-26H,5-20H2,(H,29,31)(H,30,32)
InChIKey
NISHVKOYJUQOBR-UHFFFAOYSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Form
Solid

Bis-PEG2-endo-BCN, a versatile bifunctional linker, finds extensive utility in bioconjugation and drug delivery realms. Here are four key applications of Bis-PEG2-endo-BCN presented with high perplexity and burstiness:

1. Targeted Drug Delivery: Bis-PEG2-endo-BCN offers a sophisticated means of directing therapeutic agents to precise cells or tissues by binding to biomolecules like antibodies. This targeted strategy minimizes off-target effects, amplifying the therapeutic potency of the drug. Its significance shines in cancer therapy, where accurate delivery to tumor cells holds paramount importance.

2. Diagnostic Imaging: Leveraging Bis-PEG2-endo-BCN, researchers can conjugate imaging agents to targeting ligands, enriching diagnostic imaging practices. This application elevates the contrast and specificity of imaging modalities such as MRI or PET scans, enabling superior visualization and early detection of diseases like cancer and cardiovascular disorders.

3. Protein-Protein Interaction Studies: Bis-PEG2-endo-BCN plays a pivotal role in probing protein-protein interactions, uniting proteins with reporter molecules. This facilitates real-time tracking of complex formation and dissociation, shedding light on protein function and signaling pathways. Unraveling these intricate interactions is indispensable for drug discovery and biochemical investigations.

4. Development of Bioconjugates: Widely embraced in bioconjugate synthesis, Bis-PEG2-endo-BCN fuels the creation of innovative constructs like antibody-drug conjugates (ADCs) and enzyme-prodrug conjugates. By tethering bioactive compounds to carriers or functional molecules, researchers craft novel therapeutics endowed with heightened stability and specificity.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA | Acid-PEG1-bis-PEG3-BCN | Fmoc-NH-Azide-PEG4-L-Lysine-PFP ester | Fmoc-NH-ethyl-SS-propionic NHS ester | Fmoc-NH-PEG2-NH2 | Bis-PEG6-NHS ester | Bis-PEG2-PFP ester | Bis-PEG8-acid | Bis-PEG1-PFP ester | Bis-PEG4-NHS ester | bis-PEG2-endo-BCN
Send Inquiry
Verification code
Inquiry Basket